Gary Charles Robb sold $147k of CORT
Chief Business Officer at CORCEPT THERAPEUTICS INC. 2,609 shares at an average of $56.20, traded Nov 22, 2024, filed Nov 26, 2024.
Score components
- +15RoleOfficer
- +11Trade size$147k at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-131176, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | SOpen-market sale Common Stock | -2,609 | $56.20 | $147k | 20,163 | Nov 26, 2024 |
| Nov 22, 2024 | GGift Common Stock | -300 | $0.00 | $0 | 19,863 | Nov 26, 2024 |
Related signals
Other insiders at CORCEPT THERAPEUTICS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 20Weak | sell 310b5-1 | CORT CORCEPT THERAPEUTICS INC | Roberto Wandenkolk Vieira President, Oncology | $30k | 296 | |
| 35Weak | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | James N Wilson director | $1.1M | 10,000 | |
| 40Moderate | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Joseph Douglas Lyon See Remarks | $1.1M | 10,000 | |
| 45Moderate | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Roberto Wandenkolk Vieira President, Oncology | $6.5M | 58,333 | |
| 40Moderate | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Sean Maduck See Remarks | $2.9M | 25,000 | |
| 30Weak | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Joseph K Belanoff Chief Executive Officer | $120k | 1,974 | |
| 5Weak | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Sean Maduck See Remarks | $103k | 1,697 | |
| 0Weak | sell 410b5-1 | CORT CORCEPT THERAPEUTICS INC | Joseph Douglas Lyon See Remarks | $26k | 421 | |
| 25Weak | sell 510b5-1 | CORT CORCEPT THERAPEUTICS INC | Daniel N Swisher JR director | $118k | 2,200 | |
| 32Weak | sell 510b5-1 | CORT CORCEPT THERAPEUTICS INC | Joseph K Belanoff Chief Executive Officer | $178k | 2,924 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.